Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Advances in Experimental Medicine and Biology
|
August 31, 2016
Non-coding RNAs Functioning in Colorectal Cancer Stem Cells
Daniele Fanale, Nadia Barraco, Angela Listì, et al.
Cancers
|
July 27, 2022
Extracellular Vesicles-ceRNAs as Ovarian Cancer Biomarkers: Looking into circRNA-miRNA-mRNA Code
Giuseppe Cammarata, Nadia Barraco, Ilaria Giusti, et al.
Translational Lung Cancer Research
|
August 25, 2021
Is there any place for PD-1/CTLA-4 inhibitors combination in the first-line treatment of advanced NSCLC?-a trial-level meta-analysis in PD-L1 selected subgroups
Francesco Passiglia, Antonio Galvano, Valerio Gristina, et al.
Diagnostics (Basel, Switzerland)
|
January 16, 2020
TTF-1/p63-Positive Poorly Differentiated NSCLC: A Histogenetic Hypothesis from the Basal Reserve Cell of the Terminal Respiratory Unit
Daniela Cabibi, Sandro Bellavia, Antonino Giulio Giannone, et al.
Journal of Oncology
|
December 13, 2019
Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1
Giuseppe Badalamenti, Nadia Barraco, Lorena Incorvaia, et al.
Therapeutic Advances in Medical Oncology
|
May 31, 2016
Nintedanib in NSCLC: evidence to date and place in therapy
Giuseppe Bronte, Francesco Passiglia, Antonio Galvano, et al.
Translational Cancer Research
|
February 4, 2022
Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer
Angela Listì, Nadia Barraco, Marco Bono, et al.
Cellular Immunology
|
February 4, 2018
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone?
Giuseppe Badalamenti, Daniele Fanale, Lorena Incorvaia, et al.
Oncotarget
|
April 16, 2016
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer?
Daniele Fanale, Valeria Amodeo, Viviana Bazan, et al.
Oncotarget
|
January 6, 2017
"Back to a false normality": new intriguing mechanisms of resistance to PARP inhibitors
Lorena Incorvaia, Francesc Passiglia, Sergio Rizzo, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Advances in Experimental Medicine and Biology
|
August 31, 2016
Non-coding RNAs Functioning in Colorectal Cancer Stem Cells
Daniele Fanale, Nadia Barraco, Angela Listì, et al.
Cancers
|
July 27, 2022
Extracellular Vesicles-ceRNAs as Ovarian Cancer Biomarkers: Looking into circRNA-miRNA-mRNA Code
Giuseppe Cammarata, Nadia Barraco, Ilaria Giusti, et al.
Translational Lung Cancer Research
|
August 25, 2021
Is there any place for PD-1/CTLA-4 inhibitors combination in the first-line treatment of advanced NSCLC?-a trial-level meta-analysis in PD-L1 selected subgroups
Francesco Passiglia, Antonio Galvano, Valerio Gristina, et al.
Diagnostics (Basel, Switzerland)
|
January 16, 2020
TTF-1/p63-Positive Poorly Differentiated NSCLC: A Histogenetic Hypothesis from the Basal Reserve Cell of the Terminal Respiratory Unit
Daniela Cabibi, Sandro Bellavia, Antonino Giulio Giannone, et al.
Journal of Oncology
|
December 13, 2019
Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1
Giuseppe Badalamenti, Nadia Barraco, Lorena Incorvaia, et al.
Therapeutic Advances in Medical Oncology
|
May 31, 2016
Nintedanib in NSCLC: evidence to date and place in therapy
Giuseppe Bronte, Francesco Passiglia, Antonio Galvano, et al.
Translational Cancer Research
|
February 4, 2022
Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer
Angela Listì, Nadia Barraco, Marco Bono, et al.
Cellular Immunology
|
February 4, 2018
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone?
Giuseppe Badalamenti, Daniele Fanale, Lorena Incorvaia, et al.
Oncotarget
|
April 16, 2016
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer?
Daniele Fanale, Valeria Amodeo, Viviana Bazan, et al.
Oncotarget
|
January 6, 2017
"Back to a false normality": new intriguing mechanisms of resistance to PARP inhibitors
Lorena Incorvaia, Francesc Passiglia, Sergio Rizzo, et al.
Page
of 4